Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
More innuendo IC
THEN WHAT DID U SEE ??
Enlighten us please
those that short and or naked short life saving treatments and medications like DCVAX. there is a special place down below where the fires rage and they will eventually answer for their sins against humanity.
Trump would want to take credit and say cancer cured on his watch lol
FLIP you are one of my favorite reads- but you are in left field on this buyout runway price argument IMHO
if Linda wants an early deal - then she leaves money on the table. A few BILLION
if she wants to maximize the buyout price then she waits until DCVAX-L
SAP is approved by US FDA and closer to filing BLA 6-12 months from now
Big pharma probably wants this tech in the 1-5 B range
Linda probably wants 10-25B dependent on the level of proof of concept.
I guarantee BP does the product launch and it will be one of the big boys
Merck, Roche, Amgen , Pfizer, BMY ETC
they all have the means to buyout NWBO at any price
It’s just a waiting game now IMHO
The message board attacks are ongoing / only the resurrected names return to start new FUD in attempts to dash the hopes of the faithful LONGS. If u have owned NWBO from higher prices then just stay the course
Big pharma has an ungodly large amount of cash on hand to buyout NWBO
SUPPOSEDLY Linda wouldn’t take less than 20-25B — that’s a pittance to the likes of ROCHE PFIZER MERCK BMY
Get top line data in the public eye and its gentlemen START YOUR ENGINES on the bidding
Dude
Wake up
The original SAP / the original trial endpoint PFS likely DID FAIL TO MEET ITS ENDPOINT
Hence all the wrangling over LONG TAILS and X # of survivors at 24/36/48/60 and beyond .
The current SOC survival stats are horrible. But NWBO didn’t see separation from SOC until beyond that magic line in the sand around 16 months.
Then the SOC PTS virtually all died and the crossover pts suddenly started to LIVE LONGER -
they didnt factor in an abnormally high crossover to DCVAX
THIS IS WHY THEY SUDDENLY HAVE TO REWRITE “war and peace” from the beginning to
RE- HYPOTHESIZE what they think they are seeing in the trial before/ after the fact
And must do so in a manner that the FDA , full of criminals as it is can’t help but give its blessing and allow us to file a BLA and seek approval
If all the conjecture over long tail and 80-100 pts still being alive is true - then I will give them a pass
on the FI-ASCO if they can rewrite the SAP now and get it done soon
End of summer at the latest
Number 2- quite possibly the dumbest statement - comment- belief on this topic
Not wanting the stock price to rise too high as not to offend BP
F-Ing please
Raise the share price enough to raise capital on your and F BIG PHARMA
LET THEM BUYOUT NWBO at a huge premium
Nope
Still own my big block 100k shares
SAP was started now / NOV 18 because that gave them the best idea of what the NEW DATA was looking like-
They are writing a massive report after a SEMI PREVIEW of what they expect the data to represent
BIGGERS Is holding, his timeline for EXTREME PROFITABILTY is holding for years not days or weeks.
The SAP work will be done when it’s done.
Likely won’t PR submitting SAP only when accepted or approved
Until then we wait
the SAP will take as long as it takes. Another month, two or three big deal.
I am very interested in who is financing the DIRECT TRIAL .
Yes we have cash in bank but that will run dry fast.
Hopefully partner buys an equity stake !!!
As someone who has to deal with queries like our SAP. The back and forth, ying and yang of bureaucracy. It’s slow and tedious. Hurry up and wait happens all the time . Some of it your fault some of it agency fault.
No one likes the slow pace of this ordeal.
NO THEY DIDNT HAVE 3 years for the SAP. They just started because the current data told them something different than the original plan of data years ago
No one likes patience NO ONE HAS PATIENCE
the bears are winning battes - BULLS WILL WIN WAR
Lol BEARS ask pointed questions without answers and say — see they must be wrong , hiding something, etc
JR, Anders, EX et al love to ask questions, but only have a negative view of the bull thesis.
Countdown -119 minutes to liftoff
I have owned this stock for a few years - just bored enough to watch all the games being played today on the B/A
NITE IS GETTING DESPERATE, just threw another 200k block in the way of progress
Someone taking nice chunks out of NITE AT 0.33–.
15k left get em while they are hot
On the list- very quick response
Hopefully we have good news soon
Anyone have a direct link so I can update my email with NWBO
NITE at 0.335 blocking with 200k shares.
And the big boys don’t go short or long into BINARY NEWS EVENTS without a hedge
At this volume it would take six months to sell 27M Shares
He isnt the seller
But he may be adding here ??
I anticipate a day soon where positive topline data is announced.
Combination trial with XYZ BIG PHARMA begins June 2019
XYZ pharma takes equity stake in NWBO and finances said trial
Stock price vaults higher -
short squeeze begins /
bashing by the Wolfpack intensifies as the price screams higher.
That’s great for our patients.
Time for all this good news to be reflected in stock price
Shorts are throwing the kitchen sink at the bulls at 0.34 - last ditch effort by shorts to hold the line.
Appears the new VP of IR is having a positive effect on share price.
having been a pharmacist for 30 plus years, worked with focus groups naming drugs, most companies look for names that catch your attention, either something bold sounding, implies strength or power, possibly designate the drugs mechanism of action pathway,
generic name pathway-- pre-gaba-lin brand name LYRICA ??
BRAND NAME PREMARIN- A HORMONE----- PREgnant MARe urINe
they like word plays, anything that can give them a MARKETING advantage
for all
has COFER BLACK done anything tangible for us as investors, since he came on board.
I travel often with my sons hockey team.
people who I otherwise have no common link to except proximity, sitting nearby other parents in the rink suddenly are suggested to be friends on FACEBOOK.
EVEN ads that appear on social media, if you pause the screen while viewing will prompt the media to send you more similar type ads.
I hope for the sake of all the naysayers, af, all his short friends that they release news during market hours, not pre or post open/close
I wanna see the stock price gap wide open $5-10 a share then scream higher when the dogs cover
then maybe AF will truly have a depression episode
I have tried to read the thousand of posts on here on my weekends I work.
can someone briefly post the life expectancy of the comparison SOC--
while most agree the look in years ago likely didn't show separation between SOC VS DCVAX
MANY now believe there is a difference, hence why we are waiting this out again.
no one cure, ie magic bullet theory work for everyone, at least the fda is finally acknowledging that subset treatments are more ideal, less toxic, and in the long run less expensive to the healthcare system of payers
My belief Dr Rago is implying NWBO could be successful based on the secondary endpoints line
" primary endpoint not met) but was approved on secondary endpoints. $NWBO $DCVax #GBM
everyone is arguing the wrong point.
druggie
everyone already knows AF is ANTI-NWBO.
He is posting on twitter his usual garbage regarding topline data from 2017, and now about presumed VOTING irregularities.
AF is a complete HACK
naysayers attack this kind of data saying patients were cherry picked for treatment VS sickest pts got the SOC.
they will never stop at attempting to distort positive DCVAX data.
we have 20 years of SOC data that says the SOC on its BEST days is a 12-18 death sentence for the vast majority of its patients, RIP.
so whatever is causing the DCVAX pts to live longer, "divine intervention, cherry picking, etc sign me up for that group
many want to argue that the crossover patients are damaging the potential results of dcvax.
its common for pts who have disease progression on the SOC to immediately transition "if they want to" to THE COMPARISION treatment. patients who have disease progression in trials are faced with many horrible choices. refuse further treatment do to finances, treatment exhaustion, last resorts, etc.
dx progression in GBM-- U DONT GET MANY OPTIONS FOR EXTENDING YOUR LIFE,
its not like prostate cancer where u can still live 5-15 still productive years upon diagnosis and treatment
gbm- you are truly on the survival clock 6-18 months. so the FACT that a substantial number of DCVAX pts are 36-60 months is truly remarkable.
thanks DMB, those who wish nwbo to fail only to profit from failure is inherently wrong.
I will distinguish this point.
ADAM and his pack of thieves intentionally promote misinformation, lies, deceit, in the name of "fake" journalism without facts, trying to deceive the public, make it difficult for the company to remain solvent, attack the stock by naked shorting, forcing intentional dilution and peril to the process of getting a life saving drug to market.
we all know it takes 10 years and 1-2 billion dollars to get a DRUG to market, amidst failure and process. this drug will take closer to 15-20 years and has to fight each day just to remain viable.
does the drug work..
I think it does, having seen enough data to believe that the SOC FOR GLIOBLASTOMA is a virtual death sentence in 15 months or less.
so if DCVAX DOESNT WORK, then someone explain how these patients who do get it suddenly are living 2-4x the SOC
WANNABE - EXPLAIN THIS TO US LESS INTELLIGENT
biotech companies are not perfect, they are run by humans. unfortunately many in charge are brilliant scientists without a single business minded bone in their bodies. CFOs who don't know squat about how to maintain clean financials, and raise money for the company when times are good, not when you announce bad news and have a gun to your head..
then you have the journalists, ahem... at thestreet, statnews, et al fabricating information and or fake news in an attempt to destroy future lives - I have zero patience or tolerance for those people..
biotech companies make tons of mistakes along the way to defeat and success. but let the honest process play out and let the best drugs succeed on its own merits.
its always nice when MDs in the field fail to recognize in the interview that tumor progression means FAST TRACK TO DIE for the patient. How long that actually takes is easy to determine based on previous stats of other trials or patients who refused further treatments upon progression.
Stupp conveniently doesn't address this ISSUE or the interviewer wasn't intelligent enough to ask the question.
if patients were not allowed to crossover to DCVAX, they would have died rather quickly. its agreed that the crossover patients getting dcvax does muddy the water a bit, but intelligent people should be able to roughly determine effect of the drug vs patients who would have obviously died without crossing over.
the fact that over 100 patients are still alive in a trial that began 11 years ago and the last patient was dosed more than 3 years ago should prove to the medical community that the drug does have a rather obvious positive effect on survival.
lets hope the stat geeks crunching the data are ready to finalize the results of the trial sooner than later
With potentially 10 M documented shorts and possibly 100M more naked shorts - and gap up in price on a licensing deal or buyout will push stock up another 2-3X the gap move
$10 might yield $20-30 on a short squeeze
20 might give u 40-50
This will happen and no amount of FRAUDSTEIN BASHING will save them -
Would not surprise me if ADAM was found swimming with the fishes
His hedge fund mafia friends won't like losing hundreds of millions on this gapper
CRIS - the drop U speak of is typically the buyers are exhausted short short sellers overwhelm the limited buyers with an abundance of shares and push the stock price down to a primary or secondary resistance level where the price re bases for the next leg up!! Stock price should rally to the 3.60--3.85 then charge up to 5-7 in short order if the rumors of a pivotal trial prove true
I believe the stock price will pop into double digits before year end. stock price will front run any talk of earnings / PE ratios/ approval gets us 10-12 in a decent market. spx > 1250
spx 1100 -1150 .. probably gets a 7-9 a share..
any early approval prior to march in todays markets would be greatly appreciated and will erase a previous gnvc debacle..
druggie